Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): a randomised, double-blinded, multicentre, phase 2 study

Bernt Van Den Blink, Surinder S. Birring, Nesrin Mogulkoc, Sibel Nayci Atis, Rohit Gupta, Julien Guiot, Simon P. Hart, Eva M. Carmona Porquera, Hajira B. Koeller, Natasha Arocho, Chantal M. Petit, Jill Denning, Min Lin, Robert P. Baughman, Marlies Wijsenbeek-Lourens, Theodore F. Reiss, Unknown

Open source

DOI: 10.1183/13993003.01874-2025
Published: 2026-03-12
Container: European Respiratory Journal
Publisher: European Respiratory Society (ERS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/13993003.01874-2025,
  title = {Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): a randomised, double-blinded, multicentre, phase 2 study},
  author = {Bernt Van Den Blink and Surinder S. Birring and Nesrin Mogulkoc and Sibel Nayci Atis and Rohit Gupta and Julien Guiot and Simon P. Hart and Eva M. Carmona Porquera and Hajira B. Koeller and Natasha Arocho and Chantal M. Petit and Jill Denning and Min Lin and Robert P. Baughman and Marlies Wijsenbeek-Lourens and Theodore F. Reiss and Unknown},
  year = {2026},
  journal = {European Respiratory Journal},
  doi = {10.1183/13993003.01874-2025},
  url = {https://doi.org/10.1183/13993003.01874-2025}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): a randomised, double-blinded, multicentre, phase 2 study
AU  - Bernt Van Den Blink
AU  - Surinder S. Birring
AU  - Nesrin Mogulkoc
AU  - Sibel Nayci Atis
AU  - Rohit Gupta
AU  - Julien Guiot
AU  - Simon P. Hart
AU  - Eva M. Carmona Porquera
AU  - Hajira B. Koeller
AU  - Natasha Arocho
AU  - Chantal M. Petit
AU  - Jill Denning
AU  - Min Lin
AU  - Robert P. Baughman
AU  - Marlies Wijsenbeek-Lourens
AU  - Theodore F. Reiss
AU  - Unknown
PY  - 2026
JO  - European Respiratory Journal
DO  - 10.1183/13993003.01874-2025
UR  - https://doi.org/10.1183/13993003.01874-2025
ER  -

APA

Blink, B. V. D., Birring, S. S., Mogulkoc, N., Atis, S. N., Gupta, R., Guiot, J., Hart, S. P., Porquera, E. M. C., Koeller, H. B., Arocho, N., Petit, C. M., Denning, J., Lin, M., Baughman, R. P., Wijsenbeek-Lourens, M., Reiss, T. F., & Unknown (2026). Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): a randomised, double-blinded, multicentre, phase 2 study. European Respiratory Journal. https://doi.org/10.1183/13993003.01874-2025

Source records

crossref · retrieved 2026-09-27T00:33:38.205Z